Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Artelo Biosciences Announces Positive Interim Phase 2 CAReS Results for the Treatment of Cancer Anorexia-Cachexia Syndrome (CACS)

(NASDAQ:ARTL) Catalyst for Advancing Discussions with Pharmaceutical Companies that have Expressed Interest in ART27.13 for CACS

How does ART27.13’s efficacy and safety profile compare with competing CACS therapies, and what is the potential market size and reimbursement outlook? What is the expected timeline and probability of securing partnership or licensing agreements with interested pharmaceutical companies? How will the positive interim Phase 2 results for ART27.13 influence ARTL’s short‑term stock price and valuation?
Symbol: ARTL
Clinical trials
11 days ago
Read more globenewswire

ROCKWOOL A/S – transactions in connection with share buy-back programme

(ROX) Company announcement for ROCKWOOL A/S Release no. 53 – 2025 to Nasdaq Copenhagen

How does this buy-back compare to recent repurchase activities by peers in the building materials sector? What is the scale and timeline of the buy-back relative to the company's free cash flow and existing share count? How will the share buy-back programme affect ROCKWOOL's earnings per share and valuation metrics?
Symbol: ROX
Buybacks
11 days ago
Read more globenewswire

Mobix Labs, Inc. Announces Exercise of Warrants for $4.5 Million Gross Proceeds

(NASDAQ:MOBX) IRVINE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Mobix Labs, Inc. (NASDAQ: MOBX), a fabless semiconductor company delivering advanced connectivity solutions for wired and wireless...

Are there any covenants, lock‑up periods, or other restrictions attached to the exercised warrants that could influence future financing or operational flexibility? What dilution will result from issuing 5,486,467 shares at $0.8202 per share, and how might it impact EPS and the stock price? How will the $4.5 million warrant exercise affect MOBX’s cash position and runway?
Symbol: MOBX
Capital raise
11 days ago
Read more globenewswire

Come Together: 24/7 Market News Reports Investors Back VENU’s Vision with $34.5M Raise

(VENU) VENU (NYSE American: VENU) closes previously announced public offering for $34.5M

How does VENU's recent fundraising compare to recent capital raises by its main competitors and what could that mean for market positioning? What are the intended uses of the proceeds and how might they influence VENU's growth prospects? How will the $34.5M capital raise affect VENU's valuation and share price in the short term?
Symbol: VENU
Fundraising
11 days ago
Read more globenewswire